Do treatment outcomes differ for ADHD + addiction vs single diagnosis?Â
People with both ADHD and addiction face more complex treatment challenges and higher health risks than those with ADHD alone. According to NICE NG87 guidance, recovery improves when both conditions are addressed together through integrated and carefully monitored care.
How ADHD increases the risk of addiction
Research on PubMed highlights that ADHD affects dopamine and norepinephrine systems, which influence reward, motivation, and impulsive behaviour. This helps explain why people with ADHD are more prone to substance use disorders, including alcohol, nicotine, and drug misuse, as well as behavioural addictions such as gambling or gaming.
A recent UK review found that adults with ADHD are significantly more likely to develop an addiction than those without the condition, reinforcing the need for early screening and support.
Outcomes: dual diagnosis vs ADHD alone
When ADHD and addiction occur together, outcomes are poorer if each condition is treated separately. According to RCPsych guidance suggests that people with dual diagnosis experience higher rates of depression, anxiety, relapse, and social difficulties, and are at increased risk of accidents or involvement with the justice system.
However, outcomes improve when both conditions are managed through coordinated care that combines medication, psychological therapy, and structured support.
Safer medication strategies
NICE recommends considering non-stimulant options such as atomoxetine when substance misuse is a concern. For people who require stimulant treatment, modified release formulations or transdermal patches can reduce misuse risk when delivered within a clear monitoring plan. These practices align with RCPsychâs CR235 good practice guidance.
Both NHS and private services, including ADHD Certify, use NICE aligned frameworks to support medication safety and continuity of care.
Integrated and holistic care
The NHS England ADHD Taskforce reports that bringing together addiction and neurodevelopmental services leads to better engagement and improved recovery. People who receive tailored ADHD medication alongside structured addiction treatment show reduced relapse rates and improved quality of life.
Holistic care that combines pharmacological treatment with behavioural therapy, lifestyle support, and digital tools has the strongest evidence for people living with both ADHD and addiction.
Takeaway
ADHD increases vulnerability to addiction, but treatment outcomes improve when both are addressed together. According to NICE, NHS, and BMJ evidence, integrated and multi-method care provides the best chance of recovery, stability, and improved daily life.

